A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.

Kadry H, Noorani B, Cucullo L. · 2020

Read A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. by Kadry H, Noorani B, Cucullo L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7672931.txt.

Introduction

Kadry and co-authors give an overview of the blood-brain barrier and how to judge its health. The barrier controls what passes between blood and brain. Its tight seal keeps the brain's inner setting stable, which nerve cells need to work well.

The review lays out the cells and structures that form the barrier and their jobs. It explains how fluid stress helps keep the seal sound. It then links barrier breakdown to a range of brain diseases. The authors close with markers that can gauge barrier leak in the lab or in patients, with the pros and cons of each.

Catalog record

CREATORKadry H, Noorani B, Cucullo L.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE132 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7672931

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity By Hossam Kadry, Behnam Noorani, Luca Cucullo Published in: Fluids and Barriers of the CNS DOI: 10.1186/s12987-020-00230-3 ABSTRACT Abstract The blood–brain barrier is playing a critical role in controlling the influx and efflux of biological substances essential for the brain’s metabolic activity as well as neuronal function. Thus, the functional and structural integrity of the BBB is pivotal to maintain the homeostasis of the brain microenvironment. The different cells and structures contributing to developing this barrier are summarized along with the different functions that BBB plays at the brain–blood interface. We also explained the role of shear stress in maintaining BBB integrity. Furthermore, we elaborated on the clinical aspects that correlate between BBB disruption and different neurological and pathological conditions. Finally, we discussed several biomarkers that can help to assess the BBB permeability and integrity in-vitro or in-vivo and briefly explain their advantages and disadvantages. Keywords: Blood–brain barrier, Tight junctions, Transcytosis, Disruption, Permeability, Markers, CNS, Neuroinflammation, Degenerative, TEER, Integrity BACKGROUND A highly controlled microenvironment is required to promote the normal functioning of the central nervous system (CNS). The existence of a biological barrier at the blood to brain interface effectively separating the brain from the rest of the body was established after the finding of Paul Ehrlich when he noticed that a peripherally infused dye did not stain the brain tissue. His finding was further supported by later observation from his associate Goldmann as he applied the same dye to the cerebrospinal fluid. It did stain only the brain tissue without extravasating in the periphery [1]. These biological barriers are established by different cells at three key interfaces: the blood–brain barrier (BBB), blood–CSF barrier (BCB), and the arachnoid barrier [2] (see Fig. 1). [Figure: Biological barriers are protecting the brain. a Blood–brain barrier; b blood–CSF barrier; c the arachnoid barrier] The BBB is formed by microvascular endothelial cells lining the cerebral capillaries penetrating the brain and spinal cord of most mammals and other organisms with a well-developed CNS [3]. It is considered the largest interface for blood–brain exchange as the combined surface area per average adult is assumed to fall between 12 and 18 m2 based on an average microvessels surface area of 150 and 200 cm2 per gram tissue [4]. The BBB is playing a critical role in protecting the brain parenchyma from blood-borne agents and providing a significant obstacle to the entry of drugs and other exogenous compounds into the central nervous system. The second barrier is the blood–cerebrospinal fluid barrier (BCSFB), which is formed by the epithelial cells of the choroid plexus. The CSF secretion into the ventricular brain system is controlled by the choroid plexus epithelial cells [5]. In contrast, the interstitial fluid (ISF), which is consisting of the rest of the brain extracellular fluid, is derived at least partially by secretion across the capillary endothelium of the BBB [6–9]. ISF communicates freely with CSF over several locations, and its contribution to CSF is estimated between 10 and 60% [2]. Underlying the dura mater, we find the avascular arachnoid epithelium, which is considered the third barrier. The dura mater covers the CNS and completes the seal between the extracellular fluids of the central nervous system and the rest of the body [10]. Its contribution to the exchange between blood and brain is insignificant due to its avascular nature and the relatively small surface area compared to other barriers [11]. In this review, we will focus more on BBB as it is the main barrier contributing to CNS protection and maintaining the brain homeostasis. Unlike other vascular endothelial cells lining peripheral blood vessels, brain microvascular endothelial cells present distinctive morphological, structural, and functional characteristics that set them apart from other vascular endothelia. These include the following: (1) the expression of tight junctions (TJs), sealing the paracellular pathways between adjacent endothelial cells, thus preventing the unregulated passage of polar (water-soluble) molecules between the blood and the brain; (2) the absence of fenestrations; (3) the lack of pinocytic activity and the expression of active transport mechanisms to regulate the passage of essential molecule (including nutrients and essential amino acids) while blocking the passage of potentially undesired substance (both endogenous and xenobiotics) [12]. The transport barrier comprehends various efflux transporters, such as P-glycoprotein (P-gp) [13], breast cancer resistance protein (BCRP) [14], organic anion transporting polypeptide (OATP) [15]. These efflux systems may also share overlapping substrate affinities (such as P-gp and BCRP—[16]) actively pump compounds (including xenobiotics) out of the endothelial cells back into the blood circulation [17], resulting in reduced CNS exposure. Lastly, the presence of drug-metabolizing enzymes within the brain endothelial cells, such as CYP 450 enzymes (CYP1B1 and CYP2U1, CYP-3AF), results in the formation of the metabolic barrier [18–21]. CYP mRNAs have been found in several areas of the human brain which plays a role in neurodegenerative disease by metabolizing drugs and fatty acids [20]. For instance, CYP2U1 metabolizes fatty acids like arachidonic CYP1B1 has a role in the metabolism of endogenous compounds in the CNS [19]. CYP3A4 also showed to be functionally expressed at drug resistance of epileptic BBB and oxidizes a large group of xenobiotics, including antiepileptic drugs [22]. These integrated barrier systems, while protecting the brain from potentially harmful compounds, are also the major obstacle for delivering drugs into the CNS [23]. Overall, the BBB function as a dynamic interface regulating the brain homeostasis and protecting the CNS, which can respond to different physiological and pathological conditions [10]. The Induction and maintenance of the barrier function fall primarily on the interaction between the microvascular endothelium, the astrocytic foot processes (which invest close to 99% of the abluminal surface area of the brain capillary), and pericytes [24] (see also Fig. 2). [Figure: Cells association at- and molecular organization of the neurovascular unit (NVU)] In addition to microvascular endothelial cells, the capillary basement membrane (BM), astrocytes, pericytes (PCs) embedded within the BM, microglial and neuronal cells complete the structure of what we now refer to as the neurovascular unit (NVU) [25]. Below we provide a brief description of these cells and their role in maintaining the integrity of the BBB. DIFFERENT CELLS OF THE NVU Endothelial cells The BBB endothelial cells (ECs) in the mature mammalian brain are characterized by different features, which make them phenotypically different from other ECs located at different parts of the body. ECs are characterized by a flattened appearance, the expression of inter-endothelial tight junctions, the presence of very few caveolae at the luminal surface, and a high number of mitochondria [26] when compared to ECs from other vascular districts. During embryonic angiogenesis, the differentiation of the endothelium into a functioning barrier layer begins and is maintained during adulthood by a close inductive association with other cell types within the NVU, as we mentioned early [2]. The paracellular flux of hydrophilic molecules across the BBB endothelium is hindered by the tight junctions sealing the paracellular pathways between adjacent endothelial cells. The TJs also provide a fence around the cell, separating its luminal portion from the basolateral region [1]. Across the endothelium, there is rapid free diffusion of oxygen from the blood to the brain and carbon dioxide diffusion in the

Read the complete text